Markus Frank

Associate Professor of Pediatrics and Dermatology

Harvard Medical School

United States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Collaborators (5)

Claus Cursiefen

Pallab Maity

Universität Ulm

Andreas Kerstan

Assistant professor

Universitätsklinikum Würzburg

Maria Notara

University of Cologne

Franziska Schauer

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Markus Frank

Research Interests

Explore related searches

Contact this professor

Articles (15)

Collaborators (5)

Claus Cursiefen

Pallab Maity

Andreas Kerstan

Maria Notara

Franziska Schauer

Make your next move.

Markus Frank

Research Interests

Explore related searches

Contact this professor

Articles (15)

Potency assay to predict the anti-inflammatory capacity of a cell therapy product for macrophage-driven diseases: overcoming the challenges of assay development and validation

Epigenetic Regulation of Corneal Epithelial Differentiation by TET2

ABCB5+ Limbal Epithelial Stem Cells Inhibit Developmental but Promote Inflammatory (Lymph) Angiogenesis While Preventing Corneal Inflammation

Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues

ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa

Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5+ Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa

Angiogenin Released from ABCB5+ Stromal Precursors Improves Healing of Diabetic Wounds by Promoting Angiogenesis

Skin-Derived ABCB5+ Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine

Translational development of ABCB5<sup>+</sup> dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers.

Limbal BCAM expression identifies a proliferative progenitor population capable of holoclone formation and corneal differentiation.

Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

Allogeneic ABCB5+ mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trial.

High expression of SARS-CoV2 viral entry-related proteins in human limbal stem cells.

Human iPS cells engender corneal epithelial stem cells with holoclone-forming capabilities

Process development and safety evaluation of ABCB5<sup>+</sup> limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency.

Collaborators (5)

Claus Cursiefen

Pallab Maity

Andreas Kerstan

Maria Notara

Franziska Schauer

Make your next move.